A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
2022 · Translational Psychiatry · 19 citations
https://doi.org/10.1038/s41398-022-01819-y
A
Andreas Göteson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
333
Citations
9
h-index
7
i10-index
Andreas Göteson is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Bipolar Disorder and Treatment & Genetic Associations and Epidemiology & Tryptophan and brain disorders. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0000-0001-6118-6054Papers by this author
worksCerebrospinal fluid proteomic study of two bipolar disorder cohorts
2022 · Molecular Psychiatry · 15 citations
https://doi.org/10.1038/s41380-022-01724-2
Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy
2024 · Molecular Psychiatry · 7 citations
https://doi.org/10.1038/s41380-024-02774-4
Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls
2024 · Neuropsychobiology · 3 citations
https://doi.org/10.1159/000542888
The Swedish bipolar collection (SWEBIC)
2025 · International Journal of Bipolar Disorders · 1 citations
https://doi.org/10.1186/s40345-025-00389-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat